trending Market Intelligence /marketintelligence/en/news-insights/trending/IYmY5vNMS7oqgj4KqJf5dg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Proteostasis CFO resigns

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Proteostasis CFO resigns

Proteostasis Therapeutics Inc. CFO James DeTore will leave the company, effective Feb. 10, for personal reasons.

Brett Hagen, the company's controller and principal accounting officer, will assume certain of DeTore's duties on an interim basis, while Proteostasis searches for a permanent CFO.

Hagen previously served as a controller for BIND Therapeutics Inc.